T. Kawasaki

发表

Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma

M. Mino‐Kenudson, S. Ogino, A. Chan, 2008, BMC Cancer.

Cohort study of fatty acid synthase expression and patient survival in colon cancer.

M. Loda, J. Meyerhardt, E. Giovannucci, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Down‐regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer

M. Loda, S. Ogino, C. Fuchs, 2006, The Journal of pathology.

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

M. Loda, P. Kraft, S. Ogino, 2007, The Journal of molecular diagnostics : JMD.

TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.

M. Loda, S. Ogino, C. Fuchs, 2007, Human pathology.

Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component

M. Loda, J. Meyerhardt, S. Ogino, 2006, Modern Pathology.

PIK 3 CA Mutation in Colorectal Cancer : Relationship with Genetic and Epigenetic Alterations 1

S. Ogino, C. Fuchs, T. Kawasaki, 2014 .

Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis

M. Loda, S. Ogino, C. Fuchs, 2006, Modern Pathology.

Effects of growth factors on the growth and differentiation of mouse fetal liver epithelial cells in primary cultures

Y. Matsuzawa, T. Kawasaki, Yoshinori Doi, 2005, Journal of gastroenterology and hepatology.

CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.

M. Loda, S. Ogino, C. Fuchs, 2006, The Journal of molecular diagnostics : JMD.

Cytoplasmic localization of p27 (CDKN1B / KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability and CpG island methylator phenotype (CIMP)

M. Loda, S. Ogino, C. Fuchs, 2007 .

WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer

Hiroyuki Yamamoto, Shuji Ogino, Massimo Loda, 2008, Modern Pathology.

The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.

D. Park, M. Mino‐Kenudson, S. Ogino, 2007, The American journal of pathology.

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

Shuji Ogino, Massimo Loda, Takako Kawasaki, 2008, Gut.

LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer

S. Ogino, C. Fuchs, T. Kawasaki, 2008, International journal of cancer.

Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

M. Loda, S. Ogino, C. Fuchs, 2007, Human pathology.

A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.

Shuji Ogino, Andrew T Chan, Takako Kawasaki, 2008, Journal of the National Cancer Institute.

IGFBP 3 Promoter Methylation in Colorectal Cancer : Relationship with Microsatellite Instability , CpG Island Methylator Phenotype , and p 531

S. Ogino, C. Fuchs, T. Kawasaki, 2014 .

Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype

S. Ogino, T. Kawasaki, K. Nosho, 2008, Histopathology.

PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.

S. Ogino, C. Fuchs, T. Kawasaki, 2008, Neoplasia.

IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.

S. Ogino, C. Fuchs, T. Kawasaki, 2007, Neoplasia.

MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.

Shuji Ogino, David J Hunter, Aditi Hazra, 2007, Carcinogenesis.

Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.

J. Meyerhardt, S. Ogino, C. Fuchs, 2007, Neoplasia.

CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma

Jeffrey W. Clark, M. Loda, J. Meyerhardt, 2007, Virchows Archiv.

Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer

J. Meyerhardt, S. Ogino, C. Fuchs, 2007, Gut.

Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP

M. Loda, S. Ogino, C. Fuchs, 2007, Modern Pathology.

18 q Loss of Heterozygosity in Microsatellite Stable Colorectal Cancer

S. Ogino, C. Fuchs, T. Kawasaki, 2007 .

18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high

S. Ogino, C. Fuchs, T. Kawasaki, 2007, BMC Cancer.

Correlation of Pathologic Features With CpG Island Methylator Phenotype (CIMP) by Quantitative DNA Methylation Analysis in Colorectal Carcinoma

M. Loda, P. Laird, S. Ogino, 2006, The American journal of surgical pathology.

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies

M. Loda, P. Laird, D. Weisenberger, 2006, Gut.

Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

M. Loda, S. Ogino, C. Fuchs, 2006, Neoplasia.

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.

Shuji Ogino, Donna Spiegelman, Peter W Laird, 2006, The Journal of molecular diagnostics : JMD.

Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer

Shuji Ogino, Jeffrey W. Clark, Massimo Loda, 2005, Clinical Cancer Research.

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

M. Loda, M. Mino‐Kenudson, S. Ogino, 2005, The Journal of molecular diagnostics : JMD.

Basic fibroblast growth factor promotes the trans-differentiation of mouse bone marrow cells into hepatic lineage cells via multiple liver-enriched transcription factors.

Y. Matsuzawa, Y. Shinomura, H. Matsumoto, 2004, Journal of hepatology.

Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.

M. Loda, S. Ogino, C. Fuchs, 2007, Human pathology.

Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer

B. Rosner, E. Giovannucci, S. Ogino, 2009, Gut.

CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci

J. Meyerhardt, S. Ogino, C. Fuchs, 2008, Modern Pathology.

Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer

D. Hunter, S. Ogino, C. Fuchs, 2010, Cancer Causes & Control.

The inhibitory properties of the bovine plasuma amine oxidase activity by procaine and procainamide

Yasuo Watanabe, S. Naruse, T. Kawasaki, 1992 .

High Performance Liquid Chromatographic Analysis of the Activity of Bovine Plasma Amine Oxidase in the presence of procaine and procainamide

Yasuo Watanabe, S. Naruse, T. Kawasaki, 1993 .

A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.

E. Giovannucci, S. Ogino, C. Fuchs, 2008, Journal of the National Cancer Institute.

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

M. Loda, J. Meyerhardt, E. Giovannucci, 2008, Gut.

IGFBP3 Promoter Methylation in Colorectal Cancer: Relationship with Microsatellite Instability, CpG Island Methylator Phenotype, p53

S. Ogino, T. Kawasaki, K. Nosho, 2007 .

Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.

J. Meyerhardt, S. Ogino, C. Fuchs, 2007, Neoplasia.